Cargando...
Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study
INTRODUCTION: The INPULSIS-ON trial demonstrated that nintedanib reduced decline in forced vital capacity (FVC) and low pulmonary function (%FVC < 50%) of patients with idiopathic pulmonary fibrosis (IPF). However, there is no sufficient evidence in real world. OBJECTIVES: Reveal the utility and...
Guardado en:
| Publicado en: | Drug Des Devel Ther |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6186773/ https://ncbi.nlm.nih.gov/pubmed/30349191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S179427 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|